Recent developments in liposome-based veterinary therapeutics

Area of Science:

• Veterinary Nanomedicine
• Drug Delivery Systems
• Phospholipid Vesicles

Background:

• Nanomedicine offers novel therapeutic strategies for animals.
• Liposomes have emerged as key nanocarriers in veterinary research over the last decade.
• These nanosized vesicles are versatile, biodegradable, and possess favorable pharmacokinetic properties.

Purpose of the Study:

• To review recent advancements in liposome-based therapeutics for veterinary applications.
• To explore the potential of liposomes in treating animal cancers, enhancing vaccine efficacy, and managing pain.
• To outline the current status and future prospects of liposome delivery systems in veterinary medicine.

Main Methods:

• Literature review of recent and ongoing research on liposomes in veterinary medicine.
• Analysis of studies focusing on liposome applications in animal oncology, vaccinology, and analgesia.
• Synthesis of findings to assess the significance and future directions of liposome-based delivery.

Main Results:

• Liposomes are effective delivery platforms for various therapeutic agents in animals.
• Demonstrated efficacy in preclinical and clinical studies for animal cancer treatment.
• Promising results in enhancing vaccine immunogenicity and providing sustained analgesia.

Conclusions:

• Liposomes represent a significant and evolving tool in veterinary nanomedicine.
• Their adaptability and safety profile support broad applications in animal health.
• Continued research will likely expand the therapeutic utility of liposomes in veterinary practice.